APC Anti-Human/Mouse/Rat CD47 Antibody[MIAP410]

Introducing the APC Anti-Human/Mouse/Rat CD47 Antibody [MIAP410], a highly efficient and reliable solution for immunological research. This antibody, available in a convenient size of 100 tests, is specifically designed to target CD47, a cell surface protein that plays a crucial role in various physiological and pathological processes.

With its exceptional specificity and sensitivity, the APC Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] offers researchers a valuable tool to investigate the expression and function of CD47 in human, mouse, and rat samples. Its advanced formulation ensures accurate and reproducible results, enabling precise analysis and interpretation of experimental data.

This antibody is meticulously manufactured using state-of-the-art techniques, guaranteeing exceptional quality and performance. It has been extensively validated through rigorous testing to ensure optimal performance across a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence.

The APC Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] is characterized by its exceptional binding affinity and minimal background noise, allowing for precise and reliable detection of CD47 expression. Its versatility enables researchers to explore various research areas, such as cancer biology, immunology, and stem cell research.

Furthermore, this antibody is provided in a user-friendly format, allowing for easy integration into existing laboratory protocols. Its long shelf life ensures consistent and reliable results, making it an ideal choice for both short-term and long-term experiments.

In summary, the APC Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] is a highly effective and dependable tool for immunological research. Its exceptional specificity, sensitivity, and versatility make it an invaluable asset for scientists seeking to unravel the complexities of CD47 biology. Choose this antibody to elevate your research to new heights of precision and accuracy.